Bryce is a Senior Fellow at The New Zealand Initiative, and also the Director of the Wellington-based economic consultancy firm Capital Economics. Prior to setting this up in 1997 he was a Director of, and shareholder in, First NZ Capital. Before moving into investment banking in 1985, he worked in the New Zealand Treasury, reaching the position of Director. Bryce holds a PhD in economics from the University of Canterbury and was a Harkness Fellow at Harvard University. He is a Fellow of the Law and Economics Association of New Zealand.
Bryce is available for comment on fiscal issues, our poverty, inequality and welfare research. He also has a strong background in public policy analysis including monetary policy, capital markets research and microeconomic advisory work.
Bryce was made an Officer of the New Zealand Order of Merit in the 2025 New Year's honours for his significant contributions to public policy formation and economic research, spanning his influential work at Treasury during New Zealand's major economic reforms and his extensive research on fiscal discipline and regulatory quality.
Phone: +64 4 499 0790
In George Orwell’s “1984” dystopian novel, the Ministry of Truth was the ministry for propaganda and falsifying history. He would have appreciated the Resource Management Act 1991. Read more
The Pharmaceutical Management Agency, or Pharmac, was founded in 1993 and over time has mostly achieved its goals to lower the cost of medicines for Kiwis. Dr Bryce Wilkinson’s major new report on the agency – Pharmac: the right prescription? Read more
This report examines the strengths and weaknesses of New Zealand’s arrangements for prescription medicines. Central to them is the Pharmaceutical Management Agency, Pharmac, a Crown entity. Read more
Following the release of his new report Pharmac: The right prescription?, Bryce Wilkinson talks to Mike Hosking on Newstalk ZB about the Pharmac funding model. Bryce says Pharmac deserves credits for lowering the costs of many medicines, but he raises questions about whether the government needs to pay for medicines for everyone. Read more
The Pharmaceutical Management Agency, Pharmac, attracts plenty of praise and criticism. It has achieved notably low prices for many pharmaceutical medicines but is widely criticised for not subsidising a wider range of medicines and being slow to subsidise new medicines. Read more
Use of the disembodied “we” in official policy documents usually suggests a false agreement about future resource use when, in fact, there are deeply entrenched opposing interests. To fail to acknowledge the conflict is to fail to resolve it. Read more
The concept of modern monetary theory is back. This set of economic ideas has been around for a while but has risen to prominence recently through the work of American economist and adviser to Bernie Sanders' 2016 presidential campaign, Stephanie Kelton, whose book 'The Deficit Myth' was released in June. Read more
The public health system is a political football. Every change of administration is an opportunity to boot the ball at a different set of goalposts. Read more
Never have governments and central banks spent other people’s money more freely to support incomes and boost banking system liquidity. Never before have the world’s major central banks’ policy interest rates been clustered so close to zero, if not already in negative territory. Read more
New Zealand is now on a dangerous path to higher public debt and unprecedented money printing with no credible plan for unwinding the situation before the next crisis, warns a new report by The New Zealand Initiative. Covid-19 and the various types of lockdown responses have caused many governments to go even more heavily into debt and print money to sustain asset prices with borrowed money. Read more
For the last couple of decades, public debt and banking system liquidity has been ratcheting up around the world after each recession or market correction. But no one appears to have any credible plan for restoring public debt, liquidity or central bank policy rates to normal levels. Read more
Last Friday, I was invited to appear before Parliament’s Epidemic Response Committee on Tuesday 19 May. The topic was Budget 2020. Read more
As the country looks for ways to recover from the Covid-19 recession, the government is tweaking a few rules to help it along. One of its actions was to amend the Overseas Investment Act, or OIA. Read more
Our Senior Fellow Dr Bryce Wilkinson presented to the Epidemic Response Committee on 19 May 2020. He shared his thoughts on Budget 2020 and the impact of Covid-19 on the economy. Read more
Read our submission, written by Dr Bryce Wilkinson, to the Finance and Expenditure Committee. In summary: On 14 May, the Government introduced an Overseas Investment (Urgent Measures) Amendment Bill to the House and held its first reading on the same day. Read more